Nyberg G, Hansson R, Tietz F
Acta Med Scand Suppl. 1982;665:67-73. doi: 10.1111/j.0954-6820.1982.tb00410.x.
Single doses of labetalol (200 mg i.v. over 5 min, 200 and 400 mg orally) were given to five healthy men on three different occasions. Plasma levels were followed for up to 25 h and blood pressure for 5 h. The elimination half-life was 1.6 to 8.5 h for the first 8 h. The oral bioavailability ranged from 4 to 23%. All doses induced a significant fall in systolic blood pressure at 2 h, the peak effect occurring at 30--120 (mean 63-72) min. After intravenous administration the peak supine blood-pressure fall was significant for both systolic and diastolic blood pressure and occurred 16 min after administration.
在三个不同时间段,给五名健康男性单次服用拉贝洛尔(静脉注射200毫克,5分钟以上;口服200毫克和400毫克)。监测血浆浓度长达25小时,血压监测5小时。最初8小时的消除半衰期为1.6至8.5小时。口服生物利用度为4%至23%。所有剂量在2小时时均导致收缩压显著下降,峰值效应出现在30 - 120(平均63 - 72)分钟。静脉给药后,仰卧位血压的收缩压和舒张压峰值下降均显著,给药后16分钟出现。